Press release
Generic Injectables Market Size, Share and Analysis 2021-2026
Generic Injectables Market
Request Free Sample Report: https://www.imarcgroup.com/generic-injectables-market/requestsample
Global Generic Injectables Market Trends:
The production of generic injectables is time- and cost-efficient as they do not require extensive marketing, testing and research due to the established safety and efficacy profile of their branded counterparts. The governments of various countries are also supporting the manufacturing of generic injectables as they help in reducing the overall costs for patients, as well as healthcare providers. Apart from this, the rising prevalence of various chronic diseases, such as diabetes, cardiovascular disorders and Alzheimer’s disease, has increased the sales of generic injectables. They help in maximizing patient compliance without compromising the effectiveness of the treatment. Moreover, the leading generic drug companies are bolstering research and development (R&D) activities, engaging in acquisitions, or building their capabilities to develop complex and differentiated products. For instance, Mylan Inc. acquired the Agila injectables business from Strides Arcolab Limited to expand and strengthen its existing injectables portfolio. Some of the other factors fueling the growth of the market are the growing geriatric population, increasing drug shortages and rising patent expiry of several drugs. Looking forward, the market to exhibit strong growth during 2021-2026.
Market Breakup by Therapeutic Area:
• Oncology
• Anaesthesia
• Anti-infectives
• Parenteral Nutrition
• Cardiovascular
Oncology currently represents the largest therapeutic area, accounting for the majority of the global market share.
Market Breakup by Container
• Vials
• Ampoules
• Premix
• Prefilled Syringes
Market Breakup by Distribution Channel
• Hospitals
• Retail Pharmacy
At present, generic injectables are majorly distributed through hospitals.
Market Summary:
Region-wise, the leading position is hold the US generic injectables market. Other major regions include North America, Asia Pacific, Europe, Middle East and Africa, and Latin America.
The competitive landscape of the market has been examined, with some of the key players being:
• Hospira (Pfizer)
• Fresenius Kabi
• Hikma
• Sandoz (Novartis)
• Sagent
• Sanofi
• Baxter
Ask Analyst and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/generic-injectables-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want to need latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report. We deliver report with-in 24 hours.
Related Report by IMARC Group:
https://www.imarcgroup.com/uae-in-vitro-diagnostics-market
https://www.imarcgroup.com/gcc-in-vitro-diagnostic-devices-market
https://www.imarcgroup.com/dermal-facial-fillers-market
https://www.imarcgroup.com/lithography-systems-market
https://www.imarcgroup.com/colostomy-bags-market
https://www.imarcgroup.com/analgesics-market
https://www.imarcgroup.com/healthcare-packaging-market
https://www.imarcgroup.com/saudi-arabia-in-vitro-diagnostics-market
https://www.imarcgroup.com/active-pharmaceutical-ingredients-market
https://www.imarcgroup.com/cardiac-biomarkers-market
Contact Us
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 | www.imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generic Injectables Market Size, Share and Analysis 2021-2026 here
News-ID: 2262139 • Views: …
More Releases from IMARC Group
Report on Glucose Powder Manufacturing Plant 2025: Cost Breakdown, CapEx, OpEx, …
Glucose powder is a fine, crystalline form of dextrose derived primarily from starch sources such as corn or wheat. It is widely used in the food and beverage industry as a sweetener, energy booster, and fermentation aid, while also finding applications in pharmaceuticals and medical formulations due to its rapid energy-releasing properties. Its versatility, quick solubility, and nutritional benefits make it a valuable ingredient across multiple industries.
Setting up a glucose…
Yeast Manufacturing Plant Setup Cost Report 2025: Feasibility Study and Profit M …
Yeast is a single-celled microorganism belonging to the fungi kingdom, widely used in food, beverage, and biotechnology industries. It plays a critical role in fermentation, converting sugars into alcohol and carbon dioxide, which makes it essential in baking, brewing, and winemaking. Beyond food applications, yeast is also utilized in bioethanol production, probiotics, and biopharmaceuticals, highlighting its industrial importance and versatility.
Setting up a yeast manufacturing plant requires careful consideration of raw…
Biofertilizer Production Plant Cost Analysis Report 2025: CapEx, OpEx, and ROI E …
Biofertilizer is an eco-friendly, organic product containing living microorganisms that enhance soil fertility and promote plant growth. It is widely used in sustainable agriculture, organic farming, and soil health improvement programs. Biofertilizers include nitrogen-fixing bacteria, phosphate-solubilizing bacteria, and potassium-mobilizing microorganisms that provide essential nutrients to plants naturally. Due to their environmentally friendly properties, biofertilizers serve as a critical component in various agricultural applications, including crop production, soil restoration, and sustainable…
Chicken Powder Manufacturing Plant Cost Report 2025: A Comprehensive Guide and C …
Chicken powder is a dehydrated seasoning product made from chicken meat extract, fat, and other flavoring ingredients, often blended with salt, spices, and enhancers to create a concentrated poultry taste. It is widely used in soups, sauces, instant noodles, snacks, and ready-to-eat meals due to its ability to enhance umami flavor and provide consistent taste quality. The product has strong demand in both household and industrial food applications, making it…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…
